Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects - Contacts and Locations

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects

This study has been completed.

Study NCT00687141. Last updated on July 10, 2008. Information provided by AstraZeneca

Please refer to this study by its ClinicalTrials.gov identifier: NCT00687141

Locations


Sweden
	Research Site
	UPPSALA, Sweden
	Research Site
	LULEA, Sweden
	Research Site
	LINKOPING, Sweden
	Research Site
	STOCKHOLM, Sweden

Sponsors and Collaborators

AstraZeneca

Investigators


Principal Investigator:	Wolfgang Kühn	Quintiles ABStrandbodgatan 1S-753 23 Uppsala

Study Chair:	Erik Eliasson, MD, PhD	AstraZeneca R&D SödertäljeMedical Science S-151 85 Södertälje Sweden